经颈机器人主动脉瓣置换术:心脏外科的可能新前沿?
该研究在尸体模拟后,于2025年3月至7月对7例患者实施经颈机器人主动脉瓣置换术(TC-AVR),采用颈部切口和股动脉插管建立体外循环。结果显示无死亡、无植入后主动脉瓣反流,无并发症病例术后无需阿片类药物,平均住院3.2天。作者认为该技术可行,可能优于传统入路的患者恢复,但需进一步安全评估。
要点
- 经颈机器人主动脉瓣置换术在7例患者中可行,无死亡。
- 无并发症病例术后无需阿片类药物,平均住院3.2天。
- 术后无植入后主动脉瓣反流,术中峰值压差10±5 mmHg、平均压差5±2 mmHg。
核心结论
- 机器人经颈主动脉瓣置换术可行,可能提供优于传统入路的患者恢复,但需继续开发专用器械并进一步评估安全性。
研究设计与样本
- 在广泛尸体模拟后,于2025年3月至7月对7例患者实施经颈机器人主动脉瓣置换术的单臂研究。
主要发现
- 患者平均年龄66±8岁,71%为男性,多数为重度主动脉瓣狭窄,57%存在二叶式主动脉瓣。
- 平均主动脉阻断时间和体外循环时间分别为118分钟和218分钟,后续病例中观察到时间缩短。
- 无植入后主动脉瓣反流,术中峰值压差和平均压差分别为10±5 mmHg和5±2 mmHg。
- 无死亡;无需再次手术的无并发症病例(n=5)术后未使用阿片类药物,平均住院3.2天(2-4天)。
- 患者出院后不久即恢复日常活动,不受胸部限制。
临床怎么用
- 该技术通过颈部切口避免胸壁大切口,可能加速术后恢复并减少阿片类药物使用,但需进一步安全评估后推广。
局限性
- 样本量小(7例),为单臂研究,缺乏与传统入路的对照比较。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: From the first aortic valve replacement (AVR) in 1960, surgical approaches evolved toward reduction of surgical invasiveness and enhanced recovery. Conventional minimally invasive approaches still require postoperative opioid use and chest restrictions. To further minimize aortic valve surgery, a robotic technique for transcervical AVR (TC-AVR) was developed to avoid major chest wall incisions and to facilitate expedited recovery. METHODS: Following extensive cadaver simulations, the TC-AVR was performed in 7 patients between March and July 2025. The procedure includes cervical incision, similar to a thyroidectomy approach, representing a working port for robotic AVR. Cardiopulmonary bypass is established with femoral cannulation. After native valve excision, a conventional prosthetic valve is implanted with a running suture technique. RESULTS: Patients (mean age, 66 ± 8 years; 71% male) presented mostly with severe aortic stenosis, whereas a bicuspid aortic valve was present in 57%. Mean aortic cross-clamp and cardiopulmonary bypass times were 118 and 218 minutes, respectively, with reductions observed in later cases. There was no postimplantation aortic regurgitation, and intraoperative peak and mean gradients were 10 ± 5 mm Hg and 5 ± 2 mm Hg, respectively. There were no deaths. Postoperatively, no opioids were required for patients not needing reoperation (uncomplicated cases; n = 5), with mean in-hospital stay of 3.2 days (2-4 days). Patients resumed daily activities soon after discharge, unrestricted by chest precautions. CONCLUSIONS: Robotic TC-AVR is feasible, with the potential to offer superior patient recovery compared with traditional approaches. Accordingly, continued development of this technique and specialized instrumentation along with further safety evaluation are warranted and should be actively pursued.
引用
- Koprivanac M, Sutherland F, Svensson LG, et al. Transcervical Robotic Aortic Valve Replacement: A Possible New Frontier in Cardiac Surgery? Ann Thorac Surg. 2026. PMID: 41819246. doi:10.1016/j.athoracsur.2026.02.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。